Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4334
Title: A randomised controlled trial of a web-based multi-modal therapy program to improve executive functioning in children and adolescents with acquired brain injury
Authors: Boyd, R. N.
Piovesana, A.
Ross, S.
Lloyd, O.
Whittingham, K.
Ziviani, J.
Ware, R. S.
McKinlay, L.
Issue Date: 2017
Source: 31, (10), 2017, p. 1351-1363
Pages: 1351-1363
Journal: Clinical rehabilitation
Abstract: OBJECTIVE: To examine the efficacy of a multi-modal web-based therapy program, Move it to improve it (Mitii™) delivered at home to improve Executive Functioning (EF) in children with an acquired brain injury (ABI). DESIGN: Randomised Waitlist controlled trial. SETTING: Home environment. PARTICIPANTS: Sixty children with an ABI were matched in pairs by age and intelligence quotient then randomised to either 20-weeks of Mitii™ training or 20 weeks of Care As Usual (waitlist control; n=30; 17 males; mean age=11y, 11m (±2y, 6m); Full Scale IQ=76.24±17.84). Fifty-eight children completed baseline assessments (32 males; mean age=11.87±2.47; Full Scale IQ=75.21±16.76). MAIN MEASURES: Executive functioning was assessed on four domains: attentional control, cognitive flexibility, goal setting, and information processing using subtests from the Wechsler Intelligence Scale for Children (WISC-IV), Delis-Kaplan Executive Functioning System (D-KEFS), Comprehensive Trail Making Test (CTMT), Tower of London (TOL), and Test of Everyday Attention for Children (Tea-Ch). Executive functioning performance in everyday life was assessed via parent questionnaire (Behaviour Rating Inventory of Executive Functioning; BRIEF). RESULTS: No differences were observed at baseline measures. Groups were compared at 20-weeks using linear regression with no significant differences found between groups on all measures of EF. Out of a potential total dose of 60 hours, children in the Mitii™ group completed a mean of 17 hours of Mitii™ intervention. CONCLUSION: Results indicate no additional benefit to receiving Mitii™ compared to standard care. Mitii™, in its current form, was not shown to improve EF in children with ABI.L6284268422019-07-11
DOI: 10.1177/0269215517695373
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L628426842&from=exporthttp://dx.doi.org/10.1177/0269215517695373 |
Keywords: female;human;male;neuropsychological test;procedures;child;telerehabilitation;adolescentbrain injury;randomized controlled trial;cognitive defect;controlled study;executive function
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

90
checked on Mar 20, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.